title: Non-Parkinson movement disorders: Five new things.
abstract: SOLUTIONS TO THE MAJOR RIDDLES IN MOVEMENT DISORDERS ARE APPEARING AT A BREATHTAKING PACE: 1) loss-of-function mutations inPRRT2, which encodes a cell surface protein expressed in neurons, have been found in many patients with paroxysmal kinesigenic dyskinesias; 2) mutations inCIZ1, which encodes a protein involved in cell-cycle control at the G1-S checkpoint, have been identified in a small percentage of patients with cervical dystonia; and 3) finally, after many years of genetics and identification of more than 25 disease-associated genes, cellular studies related to the pathobiology of hereditary spastic paraplegia are converging on defects in modeling the endoplasmic reticulum and membrane trafficking. On the treatment front, the distinctive syndromes of faciobrachial dystonic seizures with anti-LRI1 antibodies and anti-N-methyl-d-aspartic acid encephalitis with orobuccolingual dyskinesias are becoming increasingly recognized by clinicians as imminently treatable conditions. Also on the treatment front, the first phase I trial of MRI-guided high-intensity focused ultrasound for essential tremor has been completed and intraoperative MRI is currently being used to place electrodes in the brains of patients with medically intractable dystonia. Definitive etiologies and efficacious treatments for non-Parkinson disease movement disorders are no longer wishful thinking.
authors: Department of Neurology, University of Tennessee Health Science Center, Memphis.
authors: Mark S
authors: MS
authors: Ledoux
references: N Engl J Med. 2011 Sep 8;365(10):927-38
references: 21899453
references: Am J Hum Genet. 2007 Mar;80(3):393-406
references: 17273961
references: Dis Model Mech. 2013 Jan;6(1):72-83
references: 22773755
references: Neurosurgery. 2012 Oct;71(4):755-63
references: 22791029
references: Am J Hum Genet. 2012 Jan 13;90(1):152-60
references: 22243967
references: Neurosurgery. 2012 Mar;70(1 Suppl Operative):95-103; discussion 103
references: 21796000
references: Arch Neurol. 2010 May;67(5):584-8
references: 20457958
references: Nat Genet. 2011 Nov 20;43(12):1252-5
references: 22101681
references: Arq Neuropsiquiatr. 2012 Apr;70(4):300-4
references: 22510741
references: Neurology. 2012 Feb 28;78(9):649-57
references: 22345219
references: Brain. 2011 Dec;134(Pt 12):3493-3501
references: 22120146
references: J Neurosci. 2011 May 18;31(20):7568-77
references: 21593342
references: Ann Neurol. 2011 May;69(5):892-900
references: 21416487
references: Parkinsonism Relat Disord. 2012 Jun;18(5):414-25
references: 22377579
references: J Neurosurg. 2010 Jun;112(6):1311-7
references: 19895197
references: Curr Opin Neurol. 2011 Aug;24(4):346-53
references: 21577108
references: Lancet Neurol. 2011 Jan;10(1):63-74
references: 21163445
references: Ann Neurol. 2012 Apr;71(4):458-69
references: 22447717
references: Ann Neurol. 2012 Aug;72(2):241-55
references: 22473710
references: Annu Rev Neurosci. 2012;35:25-47
references: 22540978